Skip to Main Content

Author Details

Cecilia Williams
Karolinska Institutet
1997
69
32
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35326563A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer.Cancers (Basel)2022
36551516SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets.Cancers (Basel)2022
35119668An Optimized ChIP-Seq Protocol to Determine Chromatin Binding of Estrogen Receptor Beta.Methods Mol Biol2022
35119656Antibody Validation for Estrogen Receptor Beta.Methods Mol Biol2022
33859619Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells.Front Endocrinol (Lausanne)2021
33572952The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers.Int J Mol Sci2021
33652085Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.Cancer Lett2021
33754337Genome-wide estrogen receptor β chromatin binding in human colon cancer cells reveals its tumor suppressor activity.Int J Cancer2021
32711097Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes.Cancer Lett2020
30262864Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.Oncogene2019
31299933Sexual dimorphism in the incidence of human cancers.BMC Cancer2019
31568691Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling.Cancer Med2019
31069797A miR-206 regulated gene landscape enhances mammary epithelial differentiation.J Cell Physiol2019
31041740Antibody Validation Strategy for Nuclear Receptors.Methods Mol Biol2019
30515752Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.Int J Cancer2019
29731978Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia.Oncotarget2018
30223066Regulation of sex hormone receptors in sexual dimorphism of human cancers.Cancer Lett2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
28643774Insufficient antibody validation challenges oestrogen receptor beta research.Nat Commun2017
28376210Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.J Natl Cancer Inst2017
28288875The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells.Cancer Lett2017
28235006Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.PLoS One2017
29184181Corrigendum: Insufficient antibody validation challenges oestrogen receptor beta research.Nat Commun2017
26148235RING finger protein 31 promotes p53 degradation in breast cancer cells.Oncogene2016
26585151Expression Profiles of Estrogen-Regulated MicroRNAs in Breast Cancer Cells.Methods Mol Biol2016
27196318Vitamin D Induces Global Gene Transcription in Human Corneal Epithelial Cells: Implications for Corneal Inflammation.Invest Ophthalmol Vis Sci2016
27283988Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.Oncotarget2016
26708506Estrogen receptor beta as target for colorectal cancer prevention.Cancer Lett2016
24954179Estrogen receptor signaling during vertebrate development.Biochim Biophys Acta2015
26426411Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.Mol Endocrinol2015
26114299Correction: Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.PLoS One2015
26088362miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene.Carcinogenesis2015
26010887Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.PLoS One2015
24192230Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.Endocr Relat Cancer2014
26167515Gestational bisphenol A exposure and testis development.Endocr Disruptors (Austin)2014
24970396Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival.FASEB J2014
25074552miR-206 inhibits cell migration through direct targeting of the actin-binding protein coronin 1C in triple-negative breast cancer.Mol Oncol2014
24830720Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.Cancer Res2014
24637950Profiling of estrogen-regulated microRNAs in breast cancer cells.J Vis Exp2014
24284790Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner.Toxicol Sci2014
24441041The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.Oncogene2014
23436804Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells.Carcinogenesis2013
24222786Oestrogen receptors in breast cancer: basic mechanisms and clinical implications.Ecancermedicalscience2013
23798566Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol a exposure as an environmental factor in increasing multiple sclerosis risk.Toxicol Sci2013
23809258Liver ÿ receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.Breast Cancer Res2013
22079223Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells.J Steroid Biochem Mol Biol2012
23028063Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.Mol Endocrinol2012
22791811Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.Carcinogenesis2012
22562546MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.Carcinogenesis2012
22427816Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.PLoS One2012
  • 1 - 50 of 69

Recommended Authors

Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Jeffery M Vahrenkamp
Huntsman Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 8
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 4
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Genevi??ve Deblois
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 2003
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 11
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 5
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 5
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 5
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 11
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 2
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 3
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 2
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 14
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 7
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 17
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 4

Collaborators

Joakim Lundeberg
KTH Royal Institute of Technology
Co-authored papers 14
Fredrik Pont??n
Uppsala University
Co-authored papers 11
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 9
Linnea Hases
KTH Royal Institute of Technology
Co-authored papers 8
Borbala Katona
Uppsala University
Co-authored papers 4
M??rten Sundberg
Uppsala University
Co-authored papers 3
Jacob Odeberg
The Arctic University of Norway
Co-authored papers 3
Anna Asplund
Uppsala University
Co-authored papers 2
Kemal Sanli
Istanbul University
Co-authored papers 1
Wenbin Liu
Co-authored papers 1
Akinyemi I Ojesina
University of Alabama at Birmingham
Co-authored papers 1
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 1
Arvind Rao
University of Michigan-Ann Arbor
Co-authored papers 1
Daniel V Samarov
National Institute of Standards and Technology
Co-authored papers 1
Pavel Sumazin
Baylor College of Medicine
Co-authored papers 1
Pieter Mestdagh
Co-authored papers 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 1
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Cheng Zhang
KTH-Royal Institute of Technology
Co-authored papers 1
Reanne Bowlby
Co-authored papers 1
Anna Ehrlund
Karolinska Institutet
Co-authored papers 1
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 1
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Devin P Sullivan
KTH - Royal Institute of Technology
Co-authored papers 1
Cecilia Lindskog
Uppsala University
Co-authored papers 1
Frida Danielsson
KTH - Royal Institute of Technology
Co-authored papers 1
Chen Wang
College of Life Sciences, Sichuan University
Co-authored papers 1
Andre Schultz
The University of Western Australia
Co-authored papers 1
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 1
Release 1.2